Skip to main content
Fig. 4 | BMC Cardiovascular Disorders

Fig. 4

From: Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study

Fig. 4

Forest plot of fixed effects included in multistate Cox regression models. A Primary analysis with ACEi/ARB versus non-ACEi/ARB groups as a fixed effect; B Sensitivity analysis where ACEi/ARB is split into ACEi and ARB groups (n = 41 excluded due to insufficient data to determine stratification). This accounts for competing risks of in-hospital death and hospital discharge up to 90 days from ICU admission. Week of ICU admission indicates calendar time. ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker, BMI body mass index, CI confidence intervals, ICU intensive care unit. Terms with an upper confidence limit greater than 5 have been truncated for presentation

Back to article page